text

Carlyle buys 20% stake in Piramal Pharma businesses

U.S.-based Carlyle Group Inc has agreed to buy a 20-percent stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about 490 million U.S. dollars, the companies said i